Search

Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium

Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

RCOphth Annual Congress - Day 3

Follow live updates and key highlights from Day 3 of the RCOphth Annual Congress.